{
  "id": 9799951,
  "title": "Inflammatory bowel disease cases in Brazil surge 5-fold over 13 years",
  "url": "https://urgent.news/2026/09/25/inflammatory-bowel-disease-cases-in-brazil-surge-5-fold-over-13-years",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T17:02:00.000Z",
  "source": {
    "name": "Agencia Brasil",
    "slug": "agencia-brasil",
    "url": "https://agenciabrasil.ebc.com.br/en/saude/noticia/2026-09/inflammatory-bowel-disease-cases-brazil-surge-5-fold-over-13-years"
  },
  "original_language": "en",
  "account": "In Brazil, the number of individuals with inflammatory bowel disease (IBD) has increased dramatically over the past 13 years, with cases rising fivefold from 2012 to 2025. According to a study presented at the 74th Brazilian Congress of Coloproctology, the incidence of these diseases – including Crohn's disease and ulcerative colitis – grew from 30 to 158 cases per 100,000 people during this period. The research, conducted by experts from the Brazilian Society of Coloproctology (SBCP) and international institutions, analyzed data from Brazil's national public health care network, SUS. The study found that the number of new cases diagnosed annually climbed from 9.35 to 12.34 during the same timeframe. IBD is an autoimmune disorder that causes a chronic inflammatory process, with both genetic and environmental factors contributing to its development. Environmental factors, such as pollution and dietary habits, are believed to play a significant role, with the consumption of ultra-processed foods containing additives potentially triggering these inflammatory diseases. Experts project that by 2035, the incidence of new cases could reach 22.7 per 100,000 citizens, leading to an estimated 264 cases per 100,000 inhabitants, a 67% increase compared to 2025. If this projection holds true, IBD could become a major public health concern in Brazil, similar to conditions like high blood pressure and diabetes. As there is currently no cure for these diseases, treatment focuses on managing the inflammatory process and alleviating symptoms. The cost of medications can be exorbitant, reaching up to BRL 500,000 per patient annually, and patients often require long-term care.",
  "summary": "The number of people with inflammatory bowel disease (IBD) increased fivefold in Brazil from 2012 to 2025. The incidence of these diseases – such as Crohn’s disease and ulcerative colitis – rose from 30 to 158 cases per 100,000 people during that time span. The data come from a study presented at the 74th Brazilian Congress of Coloproctology, which runs through this Saturday (Sep. 26) in…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}